Home/Filings/4/0001304492-24-000138
4//SEC Filing

OBRIEN MORGAN E 4

Accession 0001304492-24-000138

CIK 0001304492other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 8:31 PM ET

Size

8.6 KB

Accession

0001304492-24-000138

Insider Transaction Report

Form 4
Period: 2024-12-09
OBRIEN MORGAN E
DirectorVice Chairman of the Board
Transactions
  • Tax Payment

    Common Stock

    2024-12-09$34.05/sh76,391$2,601,11437,582 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-12-0990,0000 total
    Exercise: $25.00Exp: 2025-01-29Common Stock (90,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-09$25.00/sh+90,000$2,250,000113,973 total
Footnotes (2)
  • [F1]This price reflects the closing price of the Issuer's Common Stock on the Nasdaq Capital Market on December 9, 2024.
  • [F2]The option shares are fully vested and the option would have expired by its terms on January 29, 2025.

Issuer

Anterix Inc.

CIK 0001304492

Entity typeother

Related Parties

1
  • filerCIK 0000937846

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 8:31 PM ET
Size
8.6 KB